Comparison of Intramuscular and Intradermal Applications of Hepatitis B Vaccine in Hemodialysis Patients

Renal Failure ◽  
2006 ◽  
Vol 28 (7) ◽  
pp. 561-565 ◽  
Author(s):  
M. Kasım Karahocagil ◽  
Turan Buzgan ◽  
Hasan Irmak ◽  
Hasan Karsen ◽  
Hayrettin Akdeniz ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine Use in Chronic Hemodialysis Patients

Nephron ◽  
1996 ◽  
Vol 72 (4) ◽  
pp. 536-543 ◽  
Author(s):  
F. Fabrizi ◽  
S. Di Filippo ◽  
D. Marcelli ◽  
I. Guarnori ◽  
L. Raffaele ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis

Lower Long-term Efficiency of Intradermal Hepatitis b Vaccine Compared to the Intramuscular Route in Hemodialysis Patients

1999 ◽  
Vol 22 (11) ◽  
pp. 739-743 ◽  
Author(s):  
D.A. Vlassopoulos ◽  
D.K. Arvanitis ◽  
D.S. Lilis ◽  
K.I. Louizou ◽  
V.E. Hadjiconstantinou
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Intramuscular Route

scholarly journals Antibody response to heat-inactivated hepatitis B vaccine (CLB-3mg) in hemodialysis patients and occupational risk personnel: a one year follow-up

1988 ◽  
Vol 30 (1) ◽  
pp. 11-16
Author(s):  
C. F. T. Yoshida ◽  
C. Takahashi ◽  
L. A. C. Mercadante ◽  
I. F. Camargo ◽  
H. G. Schatzmayr
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Occupational Risk ◽  
Immunization Schedule ◽  
One Year ◽  
Sample Ratio ◽  
Healthy Persons

Immune response against hepatitis B vaccine (CLB 3mg) was evaluated in 59 hemodialysis patients and 20 occupational risk personnel. Seroconversion was induced in 52.5% and 70.0% respectively. Twelve months after the first dose, 37.5% of patients and 60.0% of occupational risk personnel had detectable anti-HBs level. Antibody level was expressed in sample ratio units (SRU). Considering only the responders, in the patients group 38.7% had a low anti-HBs response (2.1-9.9 SRU) 32.3% a medium response (10-99.9 SRU) and 29.0% a high response (>100 SRU) while in occupational risk personnel these values were 14.3%, 64.3% and 21.4% respectively. The authors suggest the use of HBV vaccines with more elevated HBsAg concentration or a reinforced immunization schedule to improve the anti-HBs response not only for patients but also for healthy persons.

Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients

1989 ◽  
Vol 87 (3) ◽  
pp. S30-S32 ◽  
Author(s):  
Miguel Bruguera ◽  
Manuel Cremades ◽  
JoséLuis Rodicio ◽  
JoséMaria Alcazar ◽  
Arturo Oliver ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine

scholarly journals Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study

2019 ◽  
Vol 34 ◽  
Author(s):  
Pitchou Yemasai Kengibe ◽  
Jean-Robert Risassy Makulo ◽  
Yannick Mayamba Nlandu ◽  
François Bompeka Lepira ◽  
Ernest Kiswaya Sumaili ◽  
...  
Keyword(s):  
Single Dose ◽  
Hepatitis B ◽  
Observational Study ◽  
Prospective Observational Study ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine

scholarly journals More about Response to Hepatitis B Vaccine in Hemodialysis Patients

Nephron ◽  
1988 ◽  
Vol 49 (2) ◽  
pp. 171-171 ◽  
Author(s):  
G. Vagelli ◽  
G. Calabrese ◽  
A. Mazzotta ◽  
G. Pratesi ◽  
M. Gonella
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine
Sign in / Sign up

Export Citation Format

Share Document